How real-world data is reshaping early diabetes detection and care

With 591 million people living with diabetes worldwide—many unaware—the disease continues to claim lives and resources despite medical advances. Reactive approaches are no longer enough to address this crisis.

This white paper explores how real-world data is transforming diabetes care through earlier detection, personalized treatments, and therapy evaluation. Learn about:

· Detecting diabetes early with autoantibody screening and glucose patterns
· Creating tailored management plans through patient stratification
· Assessing drug and device performance in real-world settings

Discover how precision medicine is turning diabetes into a proactive opportunity.